Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Sequencing » Single-Cell Study Details Development of Chemoresistant Breast Cancer

Single-Cell Study Details Development of Chemoresistant Breast Cancer

Apr 19, 2018
|
staff reporter

NEW YORK (GenomeWeb) - A pilot study using single-cell sequencing to analyze the evolution of chemotherapy-resistant triple-negative breast cancer suggests that resistance arises from pre-existing clones with genetic mutations. However, transcriptional profiles associated with the cancer subtype can develop via reprogramming in response to chemotherapy.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

May
06
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

What's Popular?

In Cancer

  1. Blood-Based Genetic Risk Score Shows Promise for Prostate Cancer Drug Response, Survival Prediction

    Premium

  2. MiR Scientific Validates Urine-Based Cancer Tests, Awaits NY State Approval

    Premium

  3. Myriad Genetics BRCA Test to be Reimbursed in Japan

  4. Adventist Health, CancerIQ Collaboration Identifying More Patients for Guidelines-Supported Genetic Testing

    Premium

  5. Cancer Researchers Discover Novel Inherited Mutation Predisposing Children to Medulloblastoma

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.